{"schema_version":"secwatch.filing_event.v1","accession":"0000049071-23-000007","form_type":"8-K","ticker":"HUM","cik":"0000049071","company_name":"HUMANA INC","filed_at":"2023-02-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.713519+00:00","generated_at":"2026-06-20T04:16:37.815914+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.82,"calibrated_materiality_score":0.82,"confidence":"high","headline":"Humana Q4 GAAP EPS -$0.12, adj. $1.62; FY23 adj. EPS guide at least $28.00","bullets":["4Q22 GAAP loss per share $0.12; adjusted EPS $1.62, up from $1.24 YoY.","FY2022 GAAP EPS $22.08; adjusted EPS $25.24, up 22% YoY.","FY2023 guidance: GAAP EPS at least $27.57, adjusted at least $28.00; reaffirms 625k MA membership growth (13.7% YoY).","Completes realignment into Insurance and CenterWell segments; CenterWell Adjusted EBITDA $325M in Q4.","Recorded $188M in charges for $1B value creation plan in Q4, impacting GAAP results."],"urls":{"canonical":"https://secwatch.observer/filing/0000049071-23-000007","json":"https://secwatch.observer/filing/0000049071-23-000007.json","markdown":"https://secwatch.observer/filing/0000049071-23-000007.md","text":"https://secwatch.observer/filing/0000049071-23-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/49071/000004907123000007/0000049071-23-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/49071/000004907123000007/hum-20230201.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T04:16:37.815914+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"20d28f576cb01ab42f0fdff82c1c0b9941bff14b","claim":"HUMANA INC reported the year ended December 31, 2022 results: revenue $92,870, EPS $22.08 per diluted share (GAAP); $25.24 per diluted share (Adjusted).","evidence_excerpt":"the recast information. 2 Humana Inc. Summary of Results (in millions, except per share amounts) 4Q22 (a) 4Q21 (b) FY 2022 (c) FY 2021 (d) CONSOLIDATED Revenues $22,439 $21,054 $92,870 $83,064 Revenues - Adjusted (non-GAAP) $22,443 $21,198 $92,993 $83,405 Pretax results ($71) ($60) $3,568 $3,354 Pretax results - Adjusted (non-GAAP) $263 $166 $4,181 $3,356 (Net","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/49071/000004907123000007/0000049071-23-000007-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2022"},{"label":"Revenue","value":"$92,870"},{"label":"EPS","value":"$22.08 per diluted share (GAAP); $25.24 per diluted share (Adjusted)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"b582d23fa67d1eb1b6458685cfed2367ceb08531","claim":"HUMANA INC reported the quarter ended December 31, 2022 results: revenue $22,439, EPS ($0.12) per diluted share (GAAP); $1.62 per diluted share (Adjusted).","evidence_excerpt":"release for the recast information. 2 Humana Inc. Summary of Results (in millions, except per share amounts) 4Q22 (a) 4Q21 (b) FY 2022 (c) FY 2021 (d) CONSOLIDATED Revenues $22,439 $21,054 $92,870 $83,064 Revenues - Adjusted (non-GAAP) $22,443 $21,198 $92,993 $83,405 Pretax results ($71) ($60) $3,568 $3,354 Pretax results - Adjusted (non-GAAP) $263 $166","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/49071/000004907123000007/0000049071-23-000007-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2022"},{"label":"Revenue","value":"$22,439"},{"label":"EPS","value":"($0.12) per diluted share (GAAP); $1.62 per diluted share (Adjusted)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"d0ed718a2a9f425b642ce5f41e10fac244b294d2","claim":"HUMANA INC reported the fiscal year ending December 31, 2023 results: EPS at least $27.57 on a GAAP basis; at least $28.00 on an Adjusted basis. Guidance initiated.","evidence_excerpt":"Announces FY 2023 EPS guidance of at least $27.57 on a GAAP basis; at least $28.00 on an Adjusted basis","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/49071/000004907123000007/0000049071-23-000007-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ending December 31, 2023"},{"label":"EPS","value":"at least $27.57 on a GAAP basis; at least $28.00 on an Adjusted basis"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}